Found: 22
Select item for more details and to access through your institution.
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 9, p. 1730, doi. 10.1093/neuonc/noad139
- By:
- Publication type:
- Article
Corrigendum to: Variation in postoperative outcomes of patients with intracranial tumors: insights from a prospective international cohort study during the COVID-19 pandemic.
- Published in:
- 2023
- Publication type:
- Correction Notice
Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomas.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 9, p. 1721, doi. 10.1093/neuonc/noad095
- By:
- Publication type:
- Article
Corrigendum to: Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1.
- Published in:
- 2023
- Publication type:
- Correction Notice
Corrigendum to: Identifying risk factors for recurrence/relapse in NF1 optic pathway gliomas: Moving forward by looking back.
- Published in:
- 2023
- Publication type:
- Correction Notice
Cell-based therapies for glioblastoma: Promising tools against tumor heterogeneity.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 9, p. 1551, doi. 10.1093/neuonc/noad092
- By:
- Publication type:
- Article
Correction to: Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma.
- Published in:
- 2023
- Publication type:
- Correction Notice
Correction to: Progress for patients with melanoma brain metastases.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 9, p. 1726, doi. 10.1093/neuonc/noad089
- Publication type:
- Article
SMARCAL1: Expanding the spectrum of genes associated with alternative lengthening of telomeres.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 9, p. 1576, doi. 10.1093/neuonc/noad084
- By:
- Publication type:
- Article
Atypical neurofibromatous lesions: Epigenetic cousins of other benign peripheral nerve sheath tumors?
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 9, p. 1656, doi. 10.1093/neuonc/noad083
- By:
- Publication type:
- Article
Prognostic evaluation of re-resection for recurrent glioblastoma using the novel RANO classification for extent of resection: A report of the RANO resect group.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 9, p. 1672, doi. 10.1093/neuonc/noad074
- By:
- Publication type:
- Article
Genetic susceptibility to cognitive decline following craniospinal irradiation for pediatric central nervous system tumors.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 9, p. 1698, doi. 10.1093/neuonc/noad072
- By:
- Publication type:
- Article
Multi-ancestry genome-wide association study of 4069 children with glioma identifies 9p21.3 risk locus.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 9, p. 1709, doi. 10.1093/neuonc/noad042
- By:
- Publication type:
- Article
Surgery and proton radiation therapy for pediatric base of skull chordomas: Long-term clinical outcomes for 204 patients.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 9, p. 1686, doi. 10.1093/neuonc/noad068
- By:
- Publication type:
- Article
Proteasomal pathway inhibition as a potential therapy for NF2-associated meningioma and schwannoma.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 9, p. 1617, doi. 10.1093/neuonc/noad037
- By:
- Publication type:
- Article
Atypical neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entities.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 9, p. 1644, doi. 10.1093/neuonc/noad053
- By:
- Publication type:
- Article
Polio virotherapy targets the malignant glioma myeloid infiltrate with diffuse microglia activation engulfing the CNS.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 9, p. 1631, doi. 10.1093/neuonc/noad052
- By:
- Publication type:
- Article
The development of a rapid patient-derived xenograft model to predict chemotherapeutic drug sensitivity/resistance in malignant glial tumors.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 9, p. 1605, doi. 10.1093/neuonc/noad047
- By:
- Publication type:
- Article
Oncogenic long noncoding RNA LINC02283 enhances PDGF receptor A-mediated signaling and drives glioblastoma tumorigenesis.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 9, p. 1592, doi. 10.1093/neuonc/noad065
- By:
- Publication type:
- Article
Sterol regulatory element-binding protein 2 maintains glioblastoma stem cells by keeping the balance between cholesterol biosynthesis and uptake.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 9, p. 1578, doi. 10.1093/neuonc/noad060
- By:
- Publication type:
- Article
A critical analysis of neuro-oncology clinical trials.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 9, p. 1658, doi. 10.1093/neuonc/noad036
- By:
- Publication type:
- Article
Cancer-associated SMARCAL1 loss-of-function mutations promote alternative lengthening of telomeres and tumorigenesis in telomerase-negative glioblastoma cells.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 9, p. 1563, doi. 10.1093/neuonc/noad022
- By:
- Publication type:
- Article